

The process of discovery and development of a molecule is complex, long and costly. Before making a decision on the offer that best meets your needs, we offer online scientific resources and our latest news to help you get to know us better. Our experts are also at your disposal to help and support you in your research and development program.
- All
- Blog
- Congress
- Scientific resource
- Webinar
- Poster
- Scientific publication
- Press release
- Press coverage
- News

Endometriosis models – research strategies
Ready to advance your endometriosis preclinical development? Download the technical sheet and discover how we help your team move your program.

Rethinking Progress in Endometriosis Treatment
Read the white paper to learn: - Why endometriosis remains difficult to diagnose and treat - How new models are replicating human disease

What Can Engineered Cells Tell You About Your Compound?
From signaling to surprises, reporter cell assays bring clarity to compound screening. Read the blog to find out what engineered cells can tell you.

Unlock the Full Potential of Cancer Drugs with MRT [Download]
Explore how MRT can extend drug value & enable targeted therapy. Download our technical sheet to learn more.

TEQ103, a novel therapeutic for the treatment of breast cancer
These results demonstrate the significant durable antitumor effect of TEQ103 driven by the total dose administered. Read the poster!

MTL-004, a promising new therapeutic for post-resection treatment of glioblastoma
MTL-004 was found to be safe and well-tolerated at a dose of 1 mg/kg, and was excreted mainly through urine. Read the poster!

Metastasis Development Induced by Intracarotid Injection
We show a new TNBC mouse model of brain metastasis, induced by intracarotid injection, while assessing BBB integrity. Read the poster!

Novel PSMA+ and FAP+ mouse models
We designed new mouse models, which could aid in the development of novel imaging or radiotherapy agents for two biomarkers. Read the poster!

Pharmacological evaluation using the AbYlink TM regio-selective conjugation technology
AbYlink is a regio-selective labeling method, enabling a one-step conjugation of payloads to the Fc domain of an antibody. Read the poster!

PDX-Derived Organoids: Insights into Cancer Stem Cells and Metastasis
Our study highlights the versatility and translational relevance of PDXOs in cancer research. Read the poster!

Debiopharm and Oncodesign Services Launch Strategic Collaboration
Debiopharm and Oncodesign Services announce the execution of a license agreement for the use of the AbYlink technology

Radioligand Binding Assays: A Lost Art in Drug Discovery?
Old-school or still essential? Explore the overlooked power of radioligand binding assays in today's research environment.